Results 231 to 240 of about 9,367,674 (350)
The Impact of Advanced Age on Clinical Outcome from an Early Invasive Strategy in Patients with Acute Coronary Syndrome. The Acute Coronary Syndrome Prospective Audit registry (ACACIA) [PDF]
R. Prakash +8 more
openalex +1 more source
ABSTRACT Rape myths, including the belief that victims frequently lie, contribute to barriers in justice, such as the disproportionate use of the “unfounded” classification—where, following an investigation, it is determined no crime occurred. This study analyzes rape report narratives tied to previously untested sexual assault kits (N = 5638) from a ...
Rachel E. Lovell +2 more
wiley +1 more source
Improving the Quality of Surgical Operative Notes at Managil Teaching Hospital, Sudan: A Clinical Audit. [PDF]
Muhammed A +19 more
europepmc +1 more source
Cannabidiol in autism: Clinical pharmacology priorities for trial design
British Journal of Clinical Pharmacology, EarlyView.
Gislei Frota Aragão +2 more
wiley +1 more source
The “Double Bind” of Gender‐Based Violence: Secondary Victimization in Courtroom Cross‐Examinations
ABSTRACT This paper examines how secondary victimization is interactionally produced during courtroom cross‐examinations of women who have experienced sexual violence. Drawing on Ethnomethodology, Conversation Analysis and Membership Categorization Analysis, the study investigates how defense attorneys invoke rape myths and gendered stereotypes to ...
Selena Mariano
wiley +1 more source
ABSTRACT The aim of this study was to better understand juror decision‐making in a less typical rape trial scenario where even prior acquaintance is disputed. Adopting an improved mock trial paradigm including a video‐recorded recreation of a genuine rape allegation and jury‐group deliberation, 156 jury‐eligible participants took part in 1 of 13 ...
Dominic Willmott, Rosie Woodhams
wiley +1 more source
Abstract Artificial intelligence and automation are no longer just buzzwords in the biopharmaceutical industry. The manufacturing of a class of biologics, comprising monoclonal antibodies, cell therapies, and gene therapies, is far more complex than that of traditional small molecule drugs.
Shyam Panjwani, Hao Wei, John Mason
wiley +1 more source

